- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
November 11, 2024Tommy Du Honored With 2024 Sheila Sonenshine Associate Pro Bono Award
-
November 7, 2024Robins Kaplan Achieves National Tier 1 Rankings in Multiple Practice Areas on 2025 Best Law Firms List
-
November 1, 2024Robins Kaplan Recognized for “Tipping the Scales” by Diversity & Flexibility Alliance
-
November 14, 2024Roots, Branches, and Wings: Risks and Rewards of Generational Wealth
-
November 18, 2024Careers in Litigation
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
November 6, 2024How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
-
September 2024Meet Our New Partner and Trial Advocacy Seminar Keynote Speaker: B. Todd Jones
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
$358 Million Settlement in Multidistrict Litigation Against Manufacturer of Benicar
August 2017
Benicar Multi-District Litigation, MDL
In a 2013 Safety Announcement, the FDA warned that the popular blood pressure medication marketed as Benicar, Benicar HCT, Azor, or Tribenzor, can cause severe intestinal problems known as spruce-like enteropathy. Symptoms of spruce-like enteropathy can include chronic diarrhea, weight loss, nausea and vomiting which may become so severe that they require hospitalization, extreme dehydration, kidney failure, and malnourishment. The FDA required that manufacturer Daiichi-Sankyo change its label to provide consumers with a warning of this potential injury.
Robins Kaplan filed dozens of claims against the manufacturer in both Federal and New Jersey State Court and, in April 2015, the federal court cases were consolidated into a multidistrict litigation (MDL) in the District of New York.
Partner Tara Sutton was appointed to the Plaintiff’s Executive Committee and the Chair of the Science Committee. Robins Kaplan mass tort partners were likewise appointed to leadership positions within the MDL. Partner Holly Dolejsi served on the Bellwether Committee of the Benicar (Olmesartan) Multi-District Litigation. Partner Rayna Kessler served as the State/Federal Coordination Chairperson for the Plaintiff Steering Committee. Tara Sutton, along with attorneys from other leadership firms, negotiated a global $358 million settlement.
Related Professionals
Rayna E. Kessler
Partner
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.